150 related articles for article (PubMed ID: 8776376)
1. Successful treatment of pemphigus vulgaris by pulsed intravenous immunoglobulin therapy.
Bewley AP; Keefe M
Br J Dermatol; 1996 Jul; 135(1):128-9. PubMed ID: 8776376
[TBL] [Abstract][Full Text] [Related]
2. The role of therapeutic plasma exchange in pemphigus vulgaris.
Sagi L; Baum S; Gendelman V; Trau H; Barzilai A
J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):82-6. PubMed ID: 20477926
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment of corticoid-resistant pemphigus with high-dose intravenous immunoglobulins].
Sibaud V; Beylot-Barry M; Doutre MS; Beylot C
Ann Dermatol Venereol; 2000 Apr; 127(4):408-10. PubMed ID: 10844264
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodies.
Lolis M; Toosi S; Czernik A; Bystryn JC
J Am Acad Dermatol; 2011 Mar; 64(3):484-9. PubMed ID: 20692723
[TBL] [Abstract][Full Text] [Related]
5. IVIg selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgaris.
Bystryn JC; Jiao D
Autoimmunity; 2006 Nov; 39(7):601-7. PubMed ID: 17101504
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of autoantibodies to desmoglein 3 in patients with therapy-resistant pemphigus vulgaris successfully treated with adjuvant intravenous immunoglobulins.
Herzog S; Schmidt E; Goebeler M; Bröcker EB; Zillikens D
Acta Derm Venereol; 2004; 84(1):48-52. PubMed ID: 15040478
[TBL] [Abstract][Full Text] [Related]
7. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK; Sharma NL; Sharma RC; Garg G
Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigus.
Czernik A; Beutner EH; Bystryn JC
J Am Acad Dermatol; 2008 May; 58(5):796-801. PubMed ID: 18423257
[TBL] [Abstract][Full Text] [Related]
9. Influence of intravenous immunoglobulin therapy on autoantibody titers to desmoglein 3 and desmoglein 1 in pemphigus vulgaris.
Sami N; Bhol KC; Ahmed RA
Eur J Dermatol; 2003; 13(4):377-81. PubMed ID: 12948919
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous immunoglobulin therapy on serum levels of IgG1 and IgG4 antidesmoglein 1 and antidesmoglein 3 antibodies in pemphigus vulgaris.
Green MG; Bystryn JC
Arch Dermatol; 2008 Dec; 144(12):1621-4. PubMed ID: 19075146
[TBL] [Abstract][Full Text] [Related]
11. Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulin therapy.
Asarch A; Razzaque Ahmed A
Pediatr Dermatol; 2009; 26(2):197-202. PubMed ID: 19419473
[TBL] [Abstract][Full Text] [Related]
12. Case of juvenile pemphigus vulgaris which responded to i.v. immunoglobulin therapy.
Matsuda H; Okamoto O; Kohno T; Takahashi A; Takeo N; Fujiwara S
J Dermatol; 2012 Jul; 39(7):660-2. PubMed ID: 21955154
[No Abstract] [Full Text] [Related]
13. Successful treatment of refractory mucosal lesions of pemphigus vulgaris using intravenous gammaglobulin as adjuvant therapy.
Wever S; Zillikens D; Bröcker EB
Br J Dermatol; 1996 Nov; 135(5):862-3. PubMed ID: 8977702
[No Abstract] [Full Text] [Related]
14. [Plasma exchange in pemphigus vulgaris].
Hunziker T; Schwarzenbach HR; Krebs A; Nydegger UE; Camponovo F; Hess M
Schweiz Med Wochenschr; 1981 Oct; 111(44):1637-42. PubMed ID: 7302547
[TBL] [Abstract][Full Text] [Related]
15. Immunoadsorption in the treatment of pemphigus.
Mlynek A; Meurer M
Atheroscler Suppl; 2009 Dec; 10(5):107-9. PubMed ID: 20129386
[TBL] [Abstract][Full Text] [Related]
16. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris.
Hayag MV; Cohen JA; Kerdel FA
J Am Acad Dermatol; 2000 Dec; 43(6):1065-9. PubMed ID: 11100024
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins.
Shimanovich I; Nitschke M; Rose C; Grabbe J; Zillikens D
Br J Dermatol; 2008 Feb; 158(2):382-8. PubMed ID: 18070210
[TBL] [Abstract][Full Text] [Related]
18. [Intravenous immunoglobulin (TVIG) therapy in pemphigus].
Ishii N; Hashimoto T
Nihon Rinsho; 2010 Nov; 68(11):2143-6. PubMed ID: 21061546
[TBL] [Abstract][Full Text] [Related]
19. Severe pemphigus vulgaris: successful combination therapy of plasmapheresis followed by intravenous high-dose immunoglobulin to prevent rebound increase in pathogenic IgG.
Aoyama Y; Nagasawa C; Nagai M; Kitajima Y
Eur J Dermatol; 2008; 18(5):557-60. PubMed ID: 18693160
[TBL] [Abstract][Full Text] [Related]
20. Recalcitrant pemphigus vulgaris: aseptic meningitis associated with intravenous immunoglobulin therapy and successful treatment with rituximab.
Ventura F; Rocha J; Fernandes JC; Machado A; Brito C
Int J Dermatol; 2013 Apr; 52(4):501-2. PubMed ID: 23451774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
